Inmune Bio INMB
NASDAQ INMB
$2.31 +0.15 (+6.72%)
As of: Aug 21, 2026 · 3:45 PM EDT

Inmune Bio (INMB) Non-Current Debt (2021 - 2024)

Inmune Bio (INMB) posted Non-Current Debt of $15.0 million for Q4 2024, up 500.0% sequentially from $2.5 million in Q3 2024.

Inmune Bio (INMB) Non-Current Debt (2021 - 2024) Analysis & Trends

Inmune Bio has reported Non-Current Debt for 4 years, with the latest figure at $15.0 million in Q4 2024.

  • Quarterly Non-Current Debt changed N/A year-over-year to $15.0 million in Q4 2024, while the trailing twelve-month figure through Dec 2024 was $15.0 million (changed N/A YoY) and the FY2024 annual result came in at $15.0 million, changed N/A from the prior year.
  • Non-Current Debt climbed to $15.0 million in Q4 2024 per INMB's latest filing, from $2.5 million in the prior quarter.
  • Over five years, Non-Current Debt peaked at $15.0 million in Q4 2024 and troughed at $2.4 million in Q3 2023.
  • A 4-year average of $9.9 million and a median of $10.9 million in 2022 frame the typical range for Non-Current Debt.
  • The sharpest annual moves came in 2023 and 2024: Non-Current Debt tumbled 80.41% in 2023, then climbed 5.22% in 2024.
  • Over 4 years, Non-Current Debt stood at $14.5 million in 2021, then tumbled by 32.93% to $9.7 million in 2022, then tumbled by 75.5% to $2.4 million in 2023, then jumped by 531.31% to $15.0 million in 2024.
  • According to Business Quant data, Non-Current Debt over the past three periods registered $15.0 million, $2.5 million, and $5.0 million for Q4 2024, Q3 2024, and Q2 2024 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Debt (Qtr)
1 Vertex Pharmaceuticals 139.09 Bn 131.23 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.66 Bn 77.66 Bn 3.93 Bn 1.99 Bn
3 Argenx Se 64.86 Bn 59.67 Bn 1.37 Bn -
4 Moderna 58.07 Bn 52.93 Bn 52.00 Mn 591.00 Mn
5 BeOne Medicines 41.87 Bn 36.77 Bn 1.53 Bn 882.16 Mn
6 Alnylam Pharmaceuticals 31.45 Bn 28.15 Bn 992.69 Mn -
7 BioNTech SE 27.90 Bn 9.51 Bn 668.28 Mn 360.97 Mn
8 Insmed 27.40 Bn 26.24 Bn 358.27 Mn 546.77 Mn
9 Royalty Pharma 27.28 Bn 26.45 Bn - 8.96 Bn
10 Inmune Bio 61.59 Mn 43.18 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2024 15.00 Mn
Sep 30, 2024 2.50 Mn
Jun 30, 2024 5.00 Mn
Mar 31, 2024 7.50 Mn
Sep 30, 2023 2.38 Mn
Jun 30, 2023 4.82 Mn
Mar 31, 2023 7.26 Mn
Dec 31, 2022 9.70 Mn
Sep 30, 2022 12.13 Mn
Jun 30, 2022 14.57 Mn
Mar 31, 2022 14.51 Mn
Dec 31, 2021 14.46 Mn
Sep 30, 2021 14.40 Mn
Jun 30, 2021 14.35 Mn